Estradiol benzoate/progesterone

Estradiol benzoate/progesterone
Combination of
Estradiol benzoate Estrogen
Progesterone Progestogen
Clinical data
Trade names Di Pro Oleosum, Duogynon, Duoton Fort T P, Emmenovis, Gestrygen, Lutofolone, Menovis, Mestrolar, Metrigen Fuerte, Nomestrol, Phenokinon-F, Pro-Estramon-S, Prodiol, Proger F, Progestediol[1][2]
Synonyms EB/P4
Routes of
administration		 Intramuscular injection
ATC code
Identifiers
CAS Number
PubChem CID

Estradiol benzoate/progesterone (EB/P4) is a combination medication formulation of estradiol benzoate, an estrogen, and progesterone, a progestogen, which is used via intramuscular injection.[1][2][3] It has been marketed under a variety of brand names including Component E-S, Component EC, Di Pro Oleosum, Duogynon, Duogynon ampule, Duogynon forte, Duogynon simplex, Duoton Fort T P, Emmenovis, Estroprogyn, Gestrygen, Implus-C, Implus S, Jephagynon, Klimovan, Limovanil, Lutofolone, Menovis, Menstrogen Forte, Mestrolar, Metrigen Fuerte, Nomestrol, Phenokinon-F, Pro-Estramon-S, Prodiol, Proger F, Progestediol, Sistocyclin, Synovex C, and Tonevex S.[1][2][3][4] The medication is available in various countries including Latin American countries, Egypt, Italy, Lebanon, Taiwan, Thailand, Turkey, Malaysia, and Ethiopia.[1][2][3]

Under the brand name Vermagest, EB/P4 (30 mg / 30 mg ampoule) is also used as an injectable form of emergency contraception within 48 hours of sexual intercourse in El Salvador, Honduras, and Nicaragua.[5][6][7]

See also

References

  1. 1 2 3 4 "Estradiol". Drugs.com. Retrieved 2018-07-31.
  2. 1 2 3 4 "Progesterone". Drugs.com. Retrieved 2018-07-31.
  3. 1 2 3 Muller (19 June 1998). European Drug Index: European Drug Registrations, Fourth Edition. CRC Press. pp. 349–. ISBN 978-3-7692-2114-5.
  4. ↑ https://pubchem.ncbi.nlm.nih.gov/compound/56840923
  5. ↑ https://www.drugs.com/international/vermagest.html
  6. ↑ IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. pp. 467–. ISBN 978-92-832-1291-1.
  7. ↑ https://www.medicamentos.com.mx/DocHTM/27809.htm



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.